← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2006Last known activity
Sep 30, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 4 trials)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06012604CollaboratorPhase 1Sep 30, 2023
- NCT06078059CollaboratorN/ANov 1, 2022
- NCT06078059Overall official - principal investigatorN/ANov 1, 2022
- NCT01021800Lead sponsorPhase 2Apr 1, 2009
- NCT00629018CollaboratorPhase 2May 1, 2006
Details
- Last known activity
- Sep 30, 2023